The life sciences industry has long been at the forefront of innovation, and 2025 promises to continue this trajectory with exciting developments in intellectual property (IP), licensing, and mergers ...
This post is the third in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions.
Paul Johns, IP litigation head for Pearce IP in New Zealand, discusses how the firm is becoming a truly trans-Tasman outfit by onboarding dual-qualified lawyers Johns previously headed the litigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback